Replies to post #631 on Cytodyn Inc (CYDY)

[Amatuer17]

Not necessarily
Also if you read the 10-Q - you will see that the r/s ratio can be between 1:2 to 1:8 - so depending on SP mgmt can use better ratio than 1:8

My bet is on the Breakthrough designation from FDA and declaration of P3 trial for monotherapy - the FDA decision will come before end of April and if positive - it will be good boost.

[misiu143]

No , on the conference call January 21 , CFO said , we hope to grow our pps organically, and CEO said answering a question if we will have RS ..."well this is with the board discretion " . He didn't say , YES or NO.